---
schema_version: "secwatch.filing_event.v1"
accession: "0000832101-23-000017"
form_type: "8-K"
ticker: "IEX"
cik: "0000832101"
company_name: "IDEX CORP /DE/"
filed_at: "2023-04-27T23:59:59+00:00"
generated_at: "2026-06-16T10:25:08.642548+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# IDEX records Q1 sales record, cuts FY2023 adj. EPS guidance amid HST inventory correction; announces acquisition

## Summary
- Record Q1 sales $845M (+13% YoY); reported EPS $1.84, adjusted EPS $2.09 (+7% vs $1.96).
- Health & Science Technologies inventory correction larger than expected; full-year adjusted EPS guidance lowered to $8.25–$8.55.
- Agreed to acquire Iridian Spectral Technologies for CAD$150M; expected to close Q2 2023.
- Operating cash flow $148M (+86% YoY); free cash flow $121M (+91%).
- FMT segment margin up 50bps to 33.0%, FSDP up 160bps to 28.5%, HST down 300bps to 28.7%.

## SEC filing metadata
- accession: 0000832101-23-000017
- form_type: 8-K
- ticker: IEX
- cik: 0000832101
- company_name: IDEX CORP /DE/
- filed_at: 2023-04-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/832101/000083210123000017/0000832101-23-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/832101/000083210123000017/iex-20230426.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000832101-23-000017
- JSON: https://secwatch.observer/filing/0000832101-23-000017.json
- Plain text: https://secwatch.observer/filing/0000832101-23-000017.txt

## Key facts
- Earnings Releases
  IDEX CORP /DE/ reported the three month period ended March 31, 2023 results: revenue $845.4 million, net income $139.8 million, EPS $1.84.
  - Period: the three month period ended March 31, 2023
  - Revenue: $845.4 million
  - Net income: $139.8 million
  - EPS: $1.84
  - Result: reported results
  source text: (847) 498-7070 IDEX REPORTS FIRST QUARTER RESULTS First Quarter 2023 Highlights (All comparisons against the first quarter of 2022 unless otherwise noted) • Record sales of $845 million, up 13% overall and 6% organically • Reported EPS of $1.84, up 1% and adjusted EPS of $2.09, up 7% • Strong operating cash flow of $148 million, up 86%; free cash flow of $121
  evidence_url: https://www.sec.gov/Archives/edgar/data/832101/000083210123000017/0000832101-23-000017-index.htm
- Earnings Releases
  IDEX CORP /DE/ reported full year 2023 results: EPS $8.25 to $8.55 per share. Guidance lowered.
  - Period: full year 2023
  - EPS: $8.25 to $8.55 per share
  - Guidance: lowered
  - Result: guidance update
  source text: Based on our current outlook, we are lowering our full year 2023 adjusted EPS guidance to $8.25 to $8.55 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/832101/000083210123000017/0000832101-23-000017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.